Acceptability and impact of a web-based Lifestyle and sElf management Education Program (LEEP) for people with epilepsy

Not Applicable

• Conditions: Epilepsy; Neurological - Epilepsy; Public Health - Health promotion/education

• Registration Number: ACTRN12615000694516
• Lead Sponsor: St Vincent's Private Hospital Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-07-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Participants will be patients who have a diagnosis of the following types of epilepsy - temporal lobe epilepsy, frontal lobe epilepsy, parietal lobe epilepsy, occipital lobe epilepsy, symptomatic generalized epilepsy, idiopathic (genetic) generalised epilepsy, and reflex epilepsy. Additionally, participants can be of any sex, cultural background, and educational background.

Exclusion Criteria

Inability to give informed consent and inability to understand English, other types of brain injury that could impact on the person’s ability to provide informed consent or ability to participate in the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Seizure frequency as assessed by self-report seizure diary.[At baseline, 3 months and 6 months after the intervention commencement.];Self-management ability assessed by Epilepsy Self-Management Scale (ESMS).[At baseline, 3 months and 6 months after the intervention commencement.];Health Related Quality of Life as assessed by the Quality of Life in Epilepsy Inventory – QOLIE-31. [At baseline, 3 months and 6 months after the intervention commencement]

Secondary Outcome Measures

Name	Time	Method
Acceptability of intervention for people with epilepsy assessed by fidelity data (routine use and adherence to program). The program is delivered to participants in mobile phone application. The application will have reporting properties available to the study team to monitor usage and completion of modules. [At 6 months after the intervention commencement.];Economic impact as assessed by direct comparison to usual care and all cause hospital admissions. Data related to hospital admissions with be extrapolated from participant's medical records.[At 6 months after the intervention commencement.];Mood will be assessed by the Neurological Disorder Depression Inventory for Epilepsy (NDDI-E). This is a Primary Outcome.[At baseline, 3 months and 6 months after the intervention commencement.];Resilience as assessed by Connor-Davidson Resilience scale CD-RISC. This is a Primary Outcome.[At baseline, 3 months and 6 months after the intervention commencement]